Home › Blog › Lead generation for medtech and healthtech: meetings with hospital decision-makers
Medtech and healthtech lead generation: who decides inside a hospital, what works by email, NHS and US rules, prices, and our MedTech result.
By Moe Alhosni · Published 31 October 2026 · 6 min read
Short answer: Lead generation for medtech and healthtech means getting a device, diagnostics or health software company into first conversations with the people inside hospitals and health systems who can champion, evaluate and approve it: clinical leads, department heads, innovation and digital teams, and procurement. Cold email works for a narrow clinical or operational problem sent to the right department. We charge per qualified meeting that took place. Deus Tech 2.0, a MedTech client, connected with key hospital decision-makers through our work.
B2B only. This page is about selling to hospitals, clinics and health systems. It is not patient acquisition, and we do not email patients.
I'm Moe Alhosni. I run ROI Maximizer. A hospital is one of the slowest buyers there is. It is also one where a single good conversation with the right clinician can start a pilot. The job of outbound is to find that clinician.
| Role | What they decide | What they need from you |
|---|---|---|
| Clinical lead or consultant (e.g. head of radiology, lead nurse for a ward) | Whether the problem is real and the product helps patients or staff | Clinical evidence, a short explanation of the workflow change |
| Department or service manager | Whether the team can use it and afford it | Time saved, staffing impact, how it fits current systems |
| Chief medical information officer, digital or innovation lead | Integration, data, digital strategy | Interoperability, data protection, security documents |
| Research lead or clinical trials unit | Research collaborations and studies | A study design, ethics route, what the hospital gets |
| Procurement, value analysis or medical devices committee | Approval to buy | Price, evidence, regulatory status, contract terms |
| Finance director | Budget and business case | Cost against savings |
The champion is almost always clinical or operational. Procurement and the committee come later. Your first email goes to the person whose day the product changes.
Systems differ. In the NHS, buying can run through trusts, regional bodies and national frameworks. In the US, larger health systems have value analysis committees and group purchasing organisations. Private clinics and ambulatory centres buy faster and with fewer people involved. Pick one setting per campaign.
Our MedTech result is published as a single line: Deus Tech 2.0 connected with key hospital decision-makers. Its founder, Yury Ausianik, says it accelerated the company's MedTech research pipeline. I do not have a meeting count, reply rate or deal figure for it that I can publish, so there is none here.
Our measured reply rates come from other sectors: 0.32% to 1.00% human replies per email sent across four 2026 client campaigns, against published averages of 0.45% (Belkins) to 3.43% (Instantly) for all industries, each counted differently (cold email statistics). Do not read any of those as a hospital rate.
Email to staff at a hospital is business email, but the institution matters. In the UK, the ICO's guidance says "You can email or text any corporate body (a company, Scottish partnership, limited liability partnership or government body)." NHS trusts are public bodies; a GP practice run as a partnership may count as individuals under the same guidance. UK GDPR still applies to the names on your list. US hospitals fall under the FTC's CAN-SPAM rules like any other business. Germany needs prior consent for email advertising even between businesses under UWG section 7. Medical device advertising rules are separate from email law, and your regulatory team owns them. The email rules for each country are in is cold email legal. This is general information, not legal advice; check with your compliance team or counsel.
One setup fee of $1,000–$3,000, then a choice of two models. Per meeting: $200–$500 for every qualified meeting that took place, with nothing to pay when a clinician does not attend. Or a flat monthly $5,000. You are not locked into a minimum term.
Most medtech campaigns sit at the top of the per-meeting range. The buyers are senior clinicians, the lists are short, and the sales cycle is long. Full details: pay per meeting lead generation pricing. Hospital deals take a long time to close, so check the numbers with the cost per meeting calculator, using your real close rate and the time a pilot takes to turn into a contract.
One healthcare result: Deus Tech 2.0, a MedTech company, connected with key hospital decision-makers. Beyond that, our published results are PR Noir and P1 Communications, both PR agencies, Blinkoo in SaaS, and StartMeUp.ai. If you need a library of medtech case studies with meeting counts, we do not have one.
Through clinical networks, conferences, distributors and key opinion leaders, with targeted outbound to the specific department whose work the product changes. A pilot or research conversation is often the first step.
The clinical lead or department manager who owns the problem, then digital and innovation leads for software. Procurement and value analysis committees come later in the process.
The ICO says you can email any corporate body, including government bodies, without prior consent under PECR, while UK GDPR still covers the personal data. GP partnerships may be treated as individuals. Check with your own counsel.
With us, a $1,000–$3,000 setup, then $200–$500 per qualified meeting that took place, or $5,000 a month flat. No minimum term, and nothing charged for a no-show.
Related reading on pricing and agency checks is under guides. To discuss your product and target departments, book 30 minutes or write to moe@roimaxi.com.
About the author: Moe Alhosni, founder of ROI Maximizer. Before that he spent four and a half years in sales at Moody's in London, most recently as Assistant Director, Sales, working with banks, asset managers and private equity firms. He runs the campaigns behind the first-hand data on this site. LinkedIn
After Moody's he was Sales Director at Coinshift, a Web3 treasury management company (2024). Before Moody's he worked at BLOM Bank France in London on settlements and customer service, including AML/KYC record updates. Full career
Or run the free GTM teardown on your own site for the ICP, cold email and numbers specific to your company.
ROI Maximizer is a trading name of M Ventures LTD, registered in England and Wales, company no. 15554493. Registered office: 4 Beau Street, Bath BA1 1QY, United Kingdom. moe@roimaxi.com
© 2024–2026 M Ventures LTD. Privacy notice · Editorial policy · Methodology · Corrections